Macrolide Antibiotic — Obstetric
Pregnancy: Safe in pregnancy; preferred macrolide for PPROM per NICE NG25
Erythromycin (PPROM / GBS in Pregnancy)
Brand names: Erythrocin, Erymax
Adult dose
Dose: PPROM: 250 mg four times daily for 10 days (or 500 mg three times daily). GBS prophylaxis (penicillin allergy, clindamycin-resistant): 500 mg IV every 6 hours intrapartum
Route: Oral / Intravenous
Frequency: Four times daily (oral); every 6 hours (IV intrapartum)
Max: 4 g/day
ORACLE I trial: oral erythromycin + co-amoxiclav for PPROM — erythromycin alone preferred (co-amoxiclav associated with increased neonatal necrotising enterocolitis). NICE NG25: erythromycin for 10 days in PPROM
Paediatric dose
Dose: Not applicable in this obstetric context N/A/kg
Route: Oral
Frequency: N/A
Max: N/A
Maternal medication
Dose adjustments
Renal
No dose adjustment required
Hepatic
Use with caution — hepatotoxicity risk with prolonged use
Paediatric weight-based calculator
Maternal medication
Clinical pearls
- ORACLE I trial (NEJM 2001): erythromycin alone for 10 days in PPROM prolongs pregnancy, reduces neonatal infection, and reduces morbidity — co-amoxiclav arm associated with neonatal NEC and should NOT be used in PPROM
- PPROM management: antenatal corticosteroids (betamethasone) + erythromycin + expectant management until 34 weeks (or earlier if complications) — RCOG Green-top 44
- GBS intrapartum prophylaxis: benzylpenicillin IV is first-line; erythromycin is a fallback for penicillin allergy when clindamycin sensitivity not confirmed — check local GBS resistance data
- GI side effects are the major tolerability issue — take with food; clarithromycin has better GI tolerability but erythromycin is preferred in pregnancy due to longer safety data
- CYP3A4 inhibitor: erythromycin has more drug interactions than azithromycin — review all concurrent medications when prescribing in pregnancy
Contraindications
- QT prolongation
- Concurrent pimozide or ergotamine use
Side effects
- GI upset (very common — nausea, vomiting, abdominal cramps)
- QT prolongation
- Hepatotoxicity (prolonged use)
- Ototoxicity (high doses IV — rare)
Interactions
- Warfarin (significantly increases INR — monitor)
- Statins (CYP3A4 inhibition — myopathy risk)
- QT-prolonging drugs (additive)
- Ergotamine (ergotism — contraindicated)
Monitoring
- QTc (if risk factors)
- LFTs (prolonged use)
- Fetal wellbeing (PPROM — CTG, biophysical profile)
- Signs of infection (chorioamnionitis)
Reference: BNFc; BNF 90; NICE NG25 (Preterm Labour and Birth); ORACLE I Trial; RCOG Green-top 44 (PPROM). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Toxoplasmosis Risk Assessment (Congenital and Immunocompromised) · Parasitic Infections
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- Pre-eclampsia Risk Assessment · Antenatal
- VTE Risk in Pregnancy (RCOG) · VTE Prevention